PF-Atlas › Clinical Trials › NCT04419506
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis
BI 1015550 · Phase 2
Registry ID
NCT04419506
Phase
Phase 2
Status
Completed
Drug / intervention
BI 1015550
Sponsor
Boehringer Ingelheim
Start
2020-07-28
About this trial
BI 1015550 is evaluated in NCT04419506, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Boehringer Ingelheim. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04419506 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.